Tianbo Jin

867 citations
68 papers · 608 indexed · h-index 15
Topics
Pharmacogenetics and Drug Metabolism (17 papers)Cancer-related molecular mechanisms research (17 papers)Drug Transport and Resistance Mechanisms (10 papers)

In The Last Decade

Tianbo Jin

64 papers receiving 601 citations

Peers

Tianbo Jin
Comparison fields: 5 of 93
  • Molecular Biology 279
  • Cancer Research 181
  • Oncology 95
  • Pharmacology 91
  • Genetics 88
Replace Konstantina Kyritsi with:
Konstantina Kyritsi United States
Madlen Matz‐Soja Germany
Céline Gheeraert France
Johanna G. Miquet Argentina
Kelly McDaniel United States
Jennifer A. Kennedy Australia
Tomas Jakobsson Sweden
Judith Magenheim Israel
Genea Edwards United States
Nobuo Sekine Japan
Tianbo Jin relative to Konstantina Kyritsi United States Konstantina Kyritsi's profile →
Citations per field
00.5×7.7×
Konstantina Kyritsi · 1×
Citations per year

Countries citing papers authored by Tianbo Jin

Since Specialization
Citations

This map shows the geographic impact of Tianbo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianbo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianbo Jin more than expected).

Fields of papers citing papers by Tianbo Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianbo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianbo Jin. The network helps show where Tianbo Jin may publish in the future.

Co-authorship network of co-authors of Tianbo Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Tianbo Jin. A scholar is included among the top collaborators of Tianbo Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianbo Jin. Tianbo Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 2
5 2
6 0
7 1
8 2
9 4
10 4
11 3
12 6
13 8
14 13
15
Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China.
21
16 1
17 3
18 4
19 6
20 60

About Tianbo Jin

Tianbo Jin is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 68 papers that have together received 608 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Cancer-related molecular mechanisms research (17 papers) and Drug Transport and Resistance Mechanisms (10 papers). The work is most often cited by research in Cancer Research (181 citations), Pharmacology (91 citations) and Endocrine and Autonomic Systems (41 citations). Tianbo Jin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tingting Geng, Guodong Gao, Hua Yang, Shiming He, Gang Li, Dongya Yuan, Yanyang Tu, Guangbin Cui, Zhiguo Zhang and Mengdan Yan. Their work appears in journals such as PLoS ONE, Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026